TheProfitWatch

RVMD - Revolution Medicines, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
47.65 2.08 (4.37%) --- --- --- -0.14 (-0.29%) 1.95 (4.09%) -0.15 (-0.29%) -0.15 (-0.29%)

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Closed

Earnings & Ratios

Basic EPS:
-1.31
Diluted EPS:
-1.31
Basic P/E:
-37.9653
Diluted P/E:
-37.9653
RSI(14) 1m:
100.0
VWAP:
49.73
RVol:
0.8869

Events

Period Kind Movement Occurred At

Related News